Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.3 EUR | -1.29% | -1.90% | +19.23% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 62.31 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+19.23% | 1.01TCr | - | ||
-7.38% | 18TCr | C+ | ||
-0.46% | 11TCr | C | ||
-6.98% | 6.61TCr | A | ||
+2.65% | 5.07TCr | B- | ||
+5.27% | 4.31TCr | B- | ||
+5.96% | 4.07TCr | B+ | ||
+19.92% | 3.16TCr | B | ||
+15.69% | 2.56TCr | A- | ||
-7.00% | 2.42TCr | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- FPH Stock
- FPLB Stock
- Ratings Fisher & Paykel Healthcare Corporation Limited